Jaideep Dudani*

Jaideep Dudani joined Lakefront Biotherapeutics in June 2026 in connection with the Ouro Medicines transaction. He was the founding Chief Executive Officer of Ouro Medicines. Prior to Ouro, he was part of the founding team of Human Immunology Biosciences (HI-Bio), leading portfolio development and strategy before its acquisition by Biogen. Earlier, he worked at Relay Therapeutics across R&D, strategy, and business development, and began his career at Vida Ventures. He is Portfolio Principal at Monograph Capital and an observer on the board of Sudo Biosciences. He holds a PhD in Biological Engineering from MIT and a BS from UCLA.

*transitional role